ORIFARM GENERICS HOLDING A/S: Financial statements 2018
CVR: 27347223
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2018. In 2018, the company reported a gross profit of EUR 846,000 and a net result of EUR 5,504,000 compared with EUR 8,507,000 the year before. That is an increase of 20.7% compared with the year before. Equity in the 2018 report amounted to EUR 35,923,000. The solvency ratio was 53%. The company had 203 employees in the financial year.
- Gross Profit
- EUR 846,000
- Profit/Loss
- EUR 5,504,000
- Equity
- EUR 35,923,000
- Total Assets
- EUR 67,716,000
- Employees
- 203
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 846K EUR | 5.5M EUR | 35.9M EUR | 203 |
| 2017 | - | 701K EUR | 8.5M EUR | 38.5M EUR | 188 |
| 2016 | - | 1M EUR | 9M EUR | 35M EUR | 165 |
| 2015 | - | 5.7M | 5.2M | 194.3M | - |
| 2014 | - | 8.2M | 4.1M | 15.3M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ORIFARM GENERICS HOLDING A/S has published its annual report for 2017. Gross profit came to DKK 701,000, and the net result was DKK 8,507,000.
As of May 15, 2018, Karsten Haumann is registered as adm. dir. of ORIFARM GENERICS HOLDING A/S.
As of May 15, 2018, Ulrik Ernst Rasmussen has stepped down as adm. dir. of ORIFARM GENERICS HOLDING A/S.
About ORIFARM GENERICS HOLDING A/S
ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.
